Articles producció científica> Bioquímica i Biotecnologia

Plasma acylcarnitines and risk of cardiovascular disease: Effect of Mediterranean diet interventions

  • Dades identificatives

    Identificador: imarina:2657255
  • Autors:

    Guasch-Ferré M., Zheng Y., Ruiz-Canela M., Hruby A., Martínez-González M.A., Clish C.B., Corella D., Estruch R., Ros E., Fitó M., Dennis C., Morales-Gil I.M., Arós F., Fiol M., Lapetra J., Serra-Majem L., Hu F.B., Salas-Salvadó J.
  • Altres:

    Autor segons l'article: Guasch-Ferré M., Zheng Y., Ruiz-Canela M., Hruby A., Martínez-González M.A., Clish C.B., Corella D., Estruch R., Ros E., Fitó M., Dennis C., Morales-Gil I.M., Arós F., Fiol M., Lapetra J., Serra-Majem L., Hu F.B., Salas-Salvadó J.
    Departament: Bioquímica i Biotecnologia
    Autor/s de la URV: Salas Salvadó, Jorge
    Paraules clau: acylcarnitines cardiovascular disease mediterranean diet predimed Acylcarnitines Cardiovascular disease Mediterranean diet Metabolomics Predimed Predimed study
    Resum: Previous studies have suggested that metabolite profiles of elevated acylcarnitines were associated with increased risk of cardiovascular disease (CVD) in populations with established coronary disease. However, to our knowledge, this association has not been evaluated in the context of primary cardiovascular prevention.We evaluated the association between 28 plasma acylcarnitine species and risk of incident CVD and the potential modifying effect of Mediterranean diet (MedDiet) interventions.We measured plasma acylcarnitines with the use of high-throughput liquid chromatography-tandem mass spectrometry at baseline and after 1 y of follow-up, both individually and classified into short-, medium-, or long-chain scores, in a case-cohort study within the Prevención con Dieta Mediterránea (PREDIMED) study, which is a randomized Mediterranean dietary intervention for primary cardiovascular prevention. A randomly selected subcohort (n = 751) and all available incident CVD cases (n = 229) after 4.8 y of follow-up were included in the current study.After adjustment for age, sex, body mass index, and other CVD risk factors, participants in the highest quartile of baseline short- and medium-chain acylcarnitines had a higher risk of CVD than did participants in the lowest quartile [HRs: 1.80 (95% CI: 1.11, 2.91; P-trend 0.01) and 1.55 (95% CI: 1.01, 2.48; P-trend = 0.04), respectively]. Increased short-chain acylcarnitines after 1 y were associated with higher risks of total CVD and stroke. Participants with higher baseline concentrations of short-, medium-, and long-chain acylcarnitines who were randomly assigned to the control group had a higher risk of CVD than did subjects with lower concentrations of acylcarnitines who were assigned to the MedDiet group.Our data support the conclusion that metabolite profiles characterized by elevated concentrations of acylcarnitines are independently associated with risks of total CVD and stroke alone in participants at high risk of CVD. MedDiet interventions may mitigate the adverse associations shown between higher concentrations of acylcarnitines and CVD. This trial was registered at www.controlled-trials.com as ISRCTN35739639.© 2016 American Society for Nutrition.
    Àrees temàtiques: Biotecnología Ciência de alimentos Ciências biológicas ii Educação física Enfermagem General medicine Medicina i Medicina ii Medicina iii Medicine (miscellaneous) Nutrição Nutrition & dietetics Nutrition and dietetics Odontología Saúde coletiva Serviço social
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Adreça de correu electrònic de l'autor: jordi.salas@urv.cat
    ISSN: 00029165
    Identificador de l'autor: 0000-0003-2700-7459
    Data d'alta del registre: 2023-02-18
    Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
    Enllaç font original: https://www.sciencedirect.com/science/article/pii/S0002916523041679?via%3Dihub
    Referència a l'article segons font original: American Journal Of Clinical Nutrition. 103 (6): 1408-1416
    Referència de l'ítem segons les normes APA: Guasch-Ferré M., Zheng Y., Ruiz-Canela M., Hruby A., Martínez-González M.A., Clish C.B., Corella D., Estruch R., Ros E., Fitó M., Dennis C., Morales-G (2016). Plasma acylcarnitines and risk of cardiovascular disease: Effect of Mediterranean diet interventions. American Journal Of Clinical Nutrition, 103(6), 1408-1416. DOI: 10.3945/ajcn.116.130492
    URL Document de llicència: http://repositori.urv.cat/ca/proteccio-de-dades/
    DOI de l'article: 10.3945/ajcn.116.130492
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2016
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Medicine (Miscellaneous),Nutrition & Dietetics,Nutrition and Dietetics
    acylcarnitines
    cardiovascular disease
    mediterranean diet
    predimed
    Acylcarnitines
    Cardiovascular disease
    Mediterranean diet
    Metabolomics
    Predimed
    Predimed study
    Biotecnología
    Ciência de alimentos
    Ciências biológicas ii
    Educação física
    Enfermagem
    General medicine
    Medicina i
    Medicina ii
    Medicina iii
    Medicine (miscellaneous)
    Nutrição
    Nutrition & dietetics
    Nutrition and dietetics
    Odontología
    Saúde coletiva
    Serviço social
    00029165
  • Documents:

  • Cerca a google

    Search to google scholar